PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.

Abstract:

:The promoter of the human ETS1 gene contains binding site motifs for transcription factors Sp1, Ap1, Ap2, ETS, PEA3 and Oct. It has been shown previously that Ap1, Ap2, and ETS are positive regulators for the transcription of the ETS1 gene and that the ETS1 gene is autoregulated. In addition, two regions on the ETS1 promoter that contain negative regulatory sequences have also been identified. In this study, GST/PEA3 and GST/ets1 fusion proteins were used in gel mobility assays to analyse the interaction between these transcription factors with the binding motifs of PEA3 and ETS in the ETS1 promoter. Promoter constructs in which the binding site motifs are mutated were used to examine the effect of mutation on the activities of transcription factors PEA3, ets1 and Oct. Reporter plasmids containing different deletion mutants of the ETS1 promoter were used to examine the effect of different transcription factors (PEA3, Oct 1 and Oct 2) upon the expression of the ETS1 gene. The results of these studies indicate that PEA3 is a strong positive regulator of the ETS1 promoter and that other transcription factors increase the activity of the ETS1 promoter in an additive rather than synergistic fashion.

journal_name

Oncogene

journal_title

Oncogene

authors

Chen JH,Wright CD

subject

Has Abstract

pub_date

1993-12-01 00:00:00

pages

3375-83

issue

12

eissn

0950-9232

issn

1476-5594

journal_volume

8

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.

    abstract::Cancer-Associated Fibroblasts (CAFs) are the most prominent stromal cell type in breast tumors. CAFs promote tumor growth and metastasis by multiple mechanisms, including by mediating tumor-promoting inflammation. Immune modulation in the tumor microenvironment plays a central role in determining disease outcome. Howe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.65

    authors: Cohen N,Shani O,Raz Y,Sharon Y,Hoffman D,Abramovitz L,Erez N

    更新日期:2017-08-01 00:00:00

  • A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.

    abstract::Kaposi's sarcoma-associated herpesvirus (KSHV) K13/vFLIP (viral Flice-inhibitory protein) induces transcription of numerous genes through NF-κB activation, including pro-inflammatory cytokines, which contribute to the pathogenesis of Kaposi's sarcoma (KS). In this study, we report that KSHV vFLIP induces the expressio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.145

    authors: Sakakibara S,Espigol-Frigole G,Gasperini P,Uldrick TS,Yarchoan R,Tosato G

    更新日期:2013-03-07 00:00:00

  • Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene.

    abstract::p53 and DNA methylation play key roles in the maintenance of genome stability. In this work, we demonstrate that the two mechanisms are linked and that p53 plays a role in the maintenance of the DNA methylation levels. The loss of p53 was shown to induce loss of DNA methylation in the TROP1 gene, a human cancer-expres...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206248

    authors: Nasr AF,Nutini M,Palombo B,Guerra E,Alberti S

    更新日期:2003-03-20 00:00:00

  • The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers.

    abstract::Polymorphisms and somatic mutations in Flap Endonuclease 1 (FEN1), an essential enzyme involved in DNA replication and repair, can lead to functional deficiencies of the FEN1 protein and a predisposition to cancer. We identified a FEN1 germline mutation that changed residue E359 to K in a patient whose family had a hi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.19

    authors: Chung L,Onyango D,Guo Z,Jia P,Dai H,Liu S,Zhou M,Lin W,Pang I,Li H,Yuan YC,Huang Q,Zheng L,Lopes J,Nicolas A,Chai W,Raz D,Reckamp KL,Shen B

    更新日期:2015-02-12 00:00:00

  • NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

    abstract::The recent years have seen a significant shift in the expectations for the therapeutic management of disseminated melanoma. The clinical success of BRAF targeted therapy suggests that long-term disease control may one day be a reality for genetically defined subgroups of melanoma patients. Despite this progress, few a...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.453

    authors: Fedorenko IV,Gibney GT,Smalley KS

    更新日期:2013-06-20 00:00:00

  • TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.

    abstract::Radioresistance becomes the major obstacle to reduce tumor recurrence and improve prognosis in the treatment of esophageal squamous cell carcinoma (ESCC). Thus new strategies for radioresistant ESCC are urgently needed. Herein, we reported that tribbles pseudokinase 3 (TRIB3) serves as a key regulator of radioresistan...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1245-0

    authors: Zhou S,Liu S,Lin C,Li Y,Ye L,Wu X,Jian Y,Dai Y,Ouyang Y,Zhao L,Liu M,Song L,Xi M

    更新日期:2020-04-01 00:00:00

  • Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.

    abstract::Mice transgenic for the leukemia oncogene E2A-PBX1 invariably develop lethal, high-grade T-cell lymphomas by 5 months of age. In this study, retroviral insertional mutagenesis was employed to identify oncogenes that cooperate with the E2A-PBX1 transgene in lymphomagenesis. Neonatal retroviral infection substantially r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201670

    authors: Feldman BJ,Reid TR,Cleary ML

    更新日期:1997-11-27 00:00:00

  • Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.

    abstract::Oligonucleotide microarray analysis was applied to assess the expression profile of 332 probe sets representing 308 genes or expressed sequence tags (ESTs) that map to chromosome 17 in order to address epigenetic events that result in alterations in gene expression in epithelial ovarian cancer (EOC). Expression profil...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206219

    authors: Presneau N,Mes-Masson AM,Ge B,Provencher D,Hudson TJ,Tonin PN

    更新日期:2003-03-13 00:00:00

  • Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.

    abstract::While studying Bim, a BH3-only proapoptotic protein, we identified an approximately 36 kDa protein, which was abundantly expressed in all five strains of primary normal human prostate (NHP) epithelial cells but significantly reduced or lost in seven prostate cancer cell lines. The approximately 36 kDa protein was subs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206196

    authors: Liu JW,Shen JJ,Tanzillo-Swarts A,Bhatia B,Maldonado CM,Person MD,Lau SS,Tang DG

    更新日期:2003-03-13 00:00:00

  • Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha-directed invasion of human basal cell carcinoma cells.

    abstract::Basal cell carcinoma (BCC) is one of the most common skin neoplasms in humans and is usually characterized by local aggressiveness with little metastatic potential, although deep invasion, recurrence, and regional and distant metastases may occur. Here, we studied the mechanism of BCC invasion. We found that human BCC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210040

    authors: Chu CY,Cha ST,Chang CC,Hsiao CH,Tan CT,Lu YC,Jee SH,Kuo ML

    更新日期:2007-04-12 00:00:00

  • Sorting out functions of sirtuins in cancer.

    abstract::The sirtuins (SIRT 1-7) comprise a family of NAD⁺-dependent protein-modifying enzymes with activities in lysine deacetylation, adenosinediphospho(ADP)-ribosylation, and/or deacylation. These enzymes are involved in the cell's stress response systems and in regulating gene expression, DNA damage repair, metabolism and ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.120

    authors: Roth M,Chen WY

    更新日期:2014-03-27 00:00:00

  • Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1.

    abstract::Mammalian nuclear Dbf2-related (NDR) kinases (LATS1 and 2, NDR1 and 2) play a role in cell proliferation, apoptosis and morphological changes. These kinases are regulated by mammalian sterile 20-like kinases (MSTs) and Mps one binder (MOB) 1. Okadaic acid (OA), which activates MST2, facilitates the complex formation o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.66

    authors: Hirabayashi S,Nakagawa K,Sumita K,Hidaka S,Kawai T,Ikeda M,Kawata A,Ohno K,Hata Y

    更新日期:2008-07-17 00:00:00

  • The p53 knowledgebase: an integrated information resource for p53 research.

    abstract::The p53 tumor suppressor protein plays a central role in maintaining genomic integrity by occupying a nodal point in the DNA damage control pathway. Here it integrates a wide variety of signals, responding in one of several ways, that is, cell cycle arrest, senescence or programmed cell death (apoptosis). Mutations in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209952

    authors: Lim YP,Lim TT,Chan YL,Song AC,Yeo BH,Vojtesek B,Coomber D,Rajagopal G,Lane D

    更新日期:2007-03-08 00:00:00

  • Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for the treatment of advanced metastatic tumors. Bisindolylmaleimide alkaloid (B...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0076-0

    authors: Li X,Ma H,Li L,Chen Y,Sun X,Dong Z,Liu JY,Zhu W,Zhang JT

    更新日期:2018-05-01 00:00:00

  • Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.

    abstract::Expression of Brca1 in mouse mammary cancer has yet to be analysed. We use a progressive model of neoplasia based on several mouse epithelial cell lines that represent distinct steps toward the fully tumorigenic state. Using RNase protection analysis because acceptable anti-Brca1 antibodies are not available we invest...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203905

    authors: Mixon M,Kittrell F,Medina D

    更新日期:2000-11-02 00:00:00

  • SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

    abstract::SPARC, also termed osteonectin, BM-40 and 43K protein, is an acidic, cysteine-rich component of the extracellular matrix that has been shown to be directly regulated by progesterone and dexamethasone and indirectly by cytokines. By RNA fingerprinting technique, we cloned a SPARC homolog from the normal human ovarian s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mok SC,Chan WY,Wong KK,Muto MG,Berkowitz RS

    更新日期:1996-05-02 00:00:00

  • EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

    abstract::Amplification and rearrangements of the epidermal growth factor receptor (EGFR) gene are frequently found in glioblastoma multiforme (GBM). The most common variant is EGFR variant III (EGFRvIII). Research suggests that EGFRvIII could be a marker for a cancer stem cell or tumor-initiating population. If amplification a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.280

    authors: Del Vecchio CA,Giacomini CP,Vogel H,Jensen KC,Florio T,Merlo A,Pollack JR,Wong AJ

    更新日期:2013-05-23 00:00:00

  • PML protein isoforms and the RBCC/TRIM motif.

    abstract::PML is a component of a multiprotein complex, termed nuclear bodies, and the PML protein was originally discovered in patients suffering from acute promyelocytic leukaemia (APL). APL is associated with a reciprocal chromosomal translocation of chromosomes 15 and 17, which results in a fusion protein comprising PML and...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204765

    authors: Jensen K,Shiels C,Freemont PS

    更新日期:2001-10-29 00:00:00

  • p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.

    abstract::The Li-Fraumeni Syndrome (LFS) is a rare, dominantly inherited syndrome that features high risk of cancers in childhood and early adulthood. Affected families tend to develop bone and soft tissue sarcomas, breast cancers, brain tumors, leukemias, and adrenocortical carcinomas. In some kindreds, the genetic abnormality...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202783

    authors: Quesnel S,Verselis S,Portwine C,Garber J,White M,Feunteun J,Malkin D,Li FP

    更新日期:1999-07-08 00:00:00

  • Identification of RASSF8 as a candidate lung tumor suppressor gene.

    abstract::The RASSF8 gene, which maps close to the KRAS2 gene, contains a RAS-associated domain and encodes a protein that is evolutionarily conserved from fish to humans. Analysis of the RASSF8 transcript revealed a complex expression pattern of 5'-UTR mRNA isoforms in normal lung and in lung adenocarcinomas (ADCAs), with no a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209422

    authors: Falvella FS,Manenti G,Spinola M,Pignatiello C,Conti B,Pastorino U,Dragani TA

    更新日期:2006-06-29 00:00:00

  • CHF: a novel factor binding to cyclin A CHR corepressor element.

    abstract::Cell cycle modulation of cyclin A expression is due to the periodic relief of a transcriptional repression mediated by a bipartite negative DNA regulatory region. The 5' element (Cell Cycle Responsive Element: CCRE; cell Cycle Dependent Element: CDE) is clearly occupied in a cyclic manner in vivo, whereas the 3' eleme...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203017

    authors: Philips A,Chambeyron S,Lamb N,Vié A,Blanchard JM

    更新日期:1999-11-04 00:00:00

  • The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.

    abstract::The c-Jun NH2-terminal kinase (JNK) pathway represents one subgroup of MAP kinases that are activated primarily by cytokines and exposure to environmental stress. Autophagy is a protein-degradation system characterized by the formation of double-membrane vacuoles termed autophagosomes. Autophagy-related gene beclin 1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.441

    authors: Li DD,Wang LL,Deng R,Tang J,Shen Y,Guo JF,Wang Y,Xia LP,Feng GK,Liu QQ,Huang WL,Zeng YX,Zhu XF

    更新日期:2009-02-12 00:00:00

  • WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.

    abstract::Ewing sarcoma (ES) is an aggressive bone and soft tissue tumor of children and young adults in which finding effective new targeted therapies is imperative. Here, we report an in-depth preclinical study of the investigational cullin-RING ubiquitin ligase (CRL) inhibitor MLN4924 in ES, as we have recently demonstrated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.153

    authors: Mackintosh C,García-Domínguez DJ,Ordóñez JL,Ginel-Picardo A,Smith PG,Sacristán MP,de Álava E

    更新日期:2013-03-14 00:00:00

  • Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells.

    abstract::Stimulation of resting W53 cells (lymphoid murine cells expressing prolactin (PRL) receptor) by PRL induced expression of growth-related immediate-early genes (IEG), and proliferation through activation of the Src kinases. Since IEG are essential for cell cycle progression, we have studied how PRL controls expression ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208002

    authors: Domínguez-Cáceres MA,García-Martínez JM,Calcabrini A,González L,Porque PG,León J,Martín-Pérez J

    更新日期:2004-09-23 00:00:00

  • A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.

    abstract::Mutations of the RET proto-oncogene are found in the majority of patients with the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN 2). A minority of cases, however, have no detectable RET mutation and there is considerable phenotypic variation within and among MEN 2 families with the same RET mutati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207826

    authors: Vanhorne JB,Andrew SD,Harrison KJ,Taylor SA,Thomas B,McDonald TJ,Ainsworth PJ,Mulligan LM

    更新日期:2005-02-03 00:00:00

  • HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

    abstract::Most cases of breast cancer (BrCa) mortality are due to vascular metastasis. BrCa cells must intravasate through endothelial cells (ECs) to enter a blood vessel in the primary tumor and then adhere to ECs and extravasate at the metastatic site. In this study we demonstrate that inhibition of hypoxia-inducible factor (...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.365

    authors: Zhang H,Wong CC,Wei H,Gilkes DM,Korangath P,Chaturvedi P,Schito L,Chen J,Krishnamachary B,Winnard PT Jr,Raman V,Zhen L,Mitzner WA,Sukumar S,Semenza GL

    更新日期:2012-04-05 00:00:00

  • Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.

    abstract::Breast cancer cells that overexpress HER-2/neu are more resistant to chemotherapeutic agents such as paclitaxel (Taxol) and docetaxel (Taxotere) than those that do not overexpress HER-2/neu. In previous work, we showed that the adenovirus type 5 E1A can repress HER-2/neu expression at the transcriptional level. Here w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201250

    authors: Ueno NT,Yu D,Hung MC

    更新日期:1997-08-18 00:00:00

  • Suppression of v-Src transformation in primary rat embryo fibroblasts.

    abstract::To understand the mechanism for resistance of primary cultures of rat embryo fibroblasts (REFs) to oncogene-induced transformation, we studied the transforming ability of a recombinant retrovirus, ZSV, containing v-src and neo genes in REFs and in the rat cell line F2408. The susceptibility of REFs to p60v-src transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Inoue H,Tavoloni N,Hanafusa H

    更新日期:1995-07-20 00:00:00

  • Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.

    abstract::The 2;13 chromosomal translocation occurs in most cases of the cancer alveolar rhabdomyosarcoma (ARMS), and juxtaposes the genes encoding the PAX3 and FKHR transcription factors. The resulting chimeric protein PAX3-FKHR is a potent transcriptional activator, and is hypothesized to function as a dominant acting oncogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207850

    authors: Xia SJ,Barr FG

    更新日期:2004-09-09 00:00:00

  • Structure of the human LC-PTP (HePTP) gene: similarity in genomic organization within protein-tyrosine phosphatase genes.

    abstract::Recently, various cDNA sequences coding protein-tyrosine phosphatases (PTPs) have been reported and their extensive similarities in the catalytic domains clarified, but knowledge of the structures and organizations of their genes is still limited. In this study, a detailed structure and organization of the human intra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Adachi M,Miyachi T,Sekiya M,Hinoda Y,Yachi A,Imai K

    更新日期:1994-10-01 00:00:00